Biomatrix's Hyalform approved in additional markets; PMA resubmission planned in U.S. Jan. 5, 1998 No Comments
Life Medical Sciences terminates Piliel trials early; refocuses R&D efforts Dec. 22, 1997 No Comments
RSS